or Try an Advanced Search...

    Technical Analysis for VERA - Vera Therapeutics, Inc.

    Grade Last Price % Change Price Change
    C 41.98 -1.66% -0.71
    VERA closed up 4.45 percent on Wednesday, May 15, 2024, on 44 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Flat Down
    Historical VERA trend table...
    Date Alert Name Type % Chg
    Crossed Above 20 DMA Bullish -1.66%
    Crossed Above 50 DMA Bullish -1.66%
    Gapped Up Strength -1.66%
    20 DMA Resistance Bearish 2.72%
    MACD Bearish Signal Line Cross Bearish 2.72%
    NR7 Range Contraction 2.72%
    Narrow Range Bar Range Contraction 2.72%
    Inside Day Range Contraction 2.72%
    20 DMA Resistance Bearish 3.02%
    Multiple of Ten Bullish Other 3.02%
    Older End-of-Day Signals for VERA ...

       Recent Intraday Alerts

    Alert Time
    Down 2 % about 2 hours ago
    Possible Inside Day about 3 hours ago
    50 DMA Support about 4 hours ago
    Down 1% about 4 hours ago
    Fell Below 50 DMA about 4 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    VERA Chart by TradingView
    Basic chart:

    Profile

    Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Life Sciences Health Care

    Is VERA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 9 Vera Therapeutics GAAP EPS of -$0.56
    May 9 Vera Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
    May 7 Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    May 6 Vera Therapeutics, Inc.'s (NASDAQ:VERA) high institutional ownership speaks for itself as stock continues to impress, up 5.0% over last week
    Apr 23 Health Care Roundup: Market Talk
    Apr 13 Could This Stock Be the Next Biotech Buyout?
    Apr 12 Insider Sells at Vera Therapeutics Inc: SVP, Finance, Chief Accounting Officer Joseph Young ...
    Apr 11 Vertex Pharmaceuticals to buy Alpine Immune Sciences in $4.9B deal
    Apr 5 ARS Pharmaceuticals, Nuvalent, and More Stocks See Action From Activist Investors
    Apr 3 Vera Therapeutics: Waiting For A Pullback
    See more VERA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 50.78
    52 Week Low 7.1
    Average Volume 980,653
    200-Day Moving Average 25.47
    50-Day Moving Average 42.13
    20-Day Moving Average 41.40
    10-Day Moving Average 43.04
    Average True Range 2.96
    RSI (14) 52.15
    ADX 13.97
    +DI 25.90
    -DI 18.17
    Chandelier Exit (Long, 3 ATRs) 39.64
    Chandelier Exit (Short, 3 ATRs) 45.21
    Upper Bollinger Bands 45.77
    Lower Bollinger Band 37.03
    Percent B (%b) 0.65
    BandWidth 21.09
    MACD Line 0.19
    MACD Signal Line 0.24
    MACD Histogram -0.0527
    Fundamentals Value
    Market Cap 2.29 Billion
    Num Shares 53.7 Million
    EPS -2.86
    Price-to-Earnings (P/E) Ratio -14.93
    Price-to-Sales 0.00
    Price-to-Book 16.31
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 46.30
    Resistance 3 (R3) 46.27 45.04 45.70
    Resistance 2 (R2) 45.04 44.12 45.05 45.50
    Resistance 1 (R1) 43.87 43.55 44.45 43.89 45.30
    Pivot Point 42.64 42.64 42.93 42.65 42.64
    Support 1 (S1) 41.46 41.72 42.05 41.49 40.08
    Support 2 (S2) 40.23 41.15 40.24 39.88
    Support 3 (S3) 39.06 40.23 39.68
    Support 4 (S4) 39.08